20 February 2020 – Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, announces full year results for the twelve months ended 31 December 2019. Executing our Strategy for Profitable Growth – Sales of £1,632.0 million, reflecting a 0.4% LFL sales increase – Adjusted operating profit increased 3.7%, on a LFL basis,... Read more
Hilden, Germany, and Germantown, Maryland, February 20, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Nigeria, the country with the largest population in Africa and one of the world’s 30 high-disease burden countries for tuberculosis (TB), has published guidelines recommending QuantiFERON®-TB Gold Plus (QFT®-Plus) in screening for latent TB infection (LTBI)... Read more
This marks the first approval for a Tecentriq-based therapy in China, less than a year after the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals in this indication Tecentriq with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy combination approved for the initial treatment of extensive-stage small cell... Read more
Researchers at St. Jude Children’s Research Hospital utilize superresolution technology Single S. pneumonia bacterium (green) with multiple influenza virions (red) all over the surface On a recent cover of Nature Microbiology, you will find superresolution microscopy images captured by the laboratory of Dr. Jason Rosch at St. Jude Children’s Research Hospital, Memphis, USA. These images,... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Feb. 4, 2020– Xylem Inc. (NYSE: XYL), a leading global water technology company focused on addressing the world’s most challenging water issues, will host its 2020 Investor and Analyst Day on Tuesday, March 31, in Atlanta, GA, at the Company’s Data Analytics & Software Center of Excellence. Xylem President and Chief Executive... Read more
Basel, 30 January 2020 Group sales increase 9%1 at constant exchange rates and 8% in Swiss francs, driven by new products, more than compensating for impact of competition from biosimilars Pharmaceuticals Division sales up 11%, resulting from high demand for recently launched medicines, led by Ocrevus, Hemlibra, Tecentriq and Perjeta Diagnostics Division sales grow by... Read more
From powder to reliable parts: a webinar highlighting light microscopy solutions Additive manufacturing is one of the top trends in academic research and industry. Its unique benefits include: New design possibilities – providing engineers with the freedom to innovate as well as light weight construction New materials – including high temperature resistance and improved mechanical... Read more
Acquisition of INTEGRATED DYNAMIC ELECTRON SOLUTIONS, INC. 2020/01/17 JEOL Ltd. (headquartered in Akishima, Tokyo; JEOL hereafter) acquired all shares of INTEGRATED DYNAMIC ELECTRON SOLUTIONS, INC. (headquartered in California, USA; IDES hereafter), an entrepreneurial venture specialized in technologies related to transmission electron microscopy (TEM hereafter), and made IDES its wholly-owned subsidiary. Background and Objective JEOL is... Read more
Learn the protocol and understand the results of gram staining in this application note Gram staining is a well established method of staining bacteria. It is an important part of the diagnosis of infectious diseases, since gram-positive and gram-negative bacteria are often treated using different antibiotics. Click to download this application note on gram staining... Read more
AUSTIN, Texas, Jan. 12, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced 2019 highlights and 2020 guidance. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). Preliminary results, contained herein, are based on management’s initial analysis of operations for the quarter and year ended December 31, 2019... Read more